Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
21.07
-0.33 (-1.54%)
At close: Jan 30, 2026

SHE:301246 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21
Cash & Equivalents
196.89745.59421.86395.19120.43264.76
Short-Term Investments
-379.25292.3190--
Trading Asset Securities
1,171900.321,466--3
Cash & Short-Term Investments
1,3682,0252,180485.19120.43267.76
Cash Growth
-18.88%-7.10%349.31%302.89%-55.02%35.06%
Accounts Receivable
666.45559.44602.64660.21458.16308.66
Other Receivables
90.7679.89141.6787.645.850.99
Receivables
757.2639.33744.3747.8504.01309.65
Inventory
287.51270.53191.51352.95384.48343.46
Other Current Assets
725.93111.3486.4378.9820.7219.84
Total Current Assets
3,1393,0463,2021,6651,030940.71
Property, Plant & Equipment
2,2772,2921,9101,620891.27592.85
Long-Term Investments
186.69203.64228.08335.12242.3597.24
Goodwill
-----6.5
Other Intangible Assets
181.24181.89183.06173.62194.1584.12
Long-Term Deferred Tax Assets
17.8117.2617.5621.2217.7214.54
Long-Term Deferred Charges
3.465.525.956.8611.9810.74
Other Long-Term Assets
97.1678.06103.953.2745.1413.82
Total Assets
5,9025,8255,6513,8752,4321,761
Accounts Payable
620.71777.27636.79934.95340.92155.08
Accrued Expenses
12.5155.2857.5465.757.9843.21
Short-Term Debt
163.159.32-17.6420.1149.26
Current Portion of Long-Term Debt
90.5377.0165.966.092.84-
Current Portion of Leases
-0.740.60.560.530.74
Current Income Taxes Payable
4.833.561.1538.2945.6539.3
Current Unearned Revenue
15.5313.8719.831.0129.6613.93
Other Current Liabilities
170.41148.94133.04165.66120.05100.93
Total Current Liabilities
1,0781,136914.831,320617.73502.45
Long-Term Debt
389.55230.36276.12341.6747.22-
Long-Term Leases
7.067.166.98.198.238.12
Long-Term Unearned Revenue
69.9168.6471.5570.4560.844.79
Long-Term Deferred Tax Liabilities
21.7721.6221.5421.3120.320.9
Total Liabilities
1,5661,4641,2911,762754.27576.27
Common Stock
400.01400.01400.01352.75352.75352.75
Additional Paid-In Capital
2,1722,1722,17222.1520.6220.62
Retained Earnings
1,8051,8181,7861,7391,304810.3
Treasury Stock
-47.15-32.8----
Comprehensive Income & Other
5.363.371.8900.460.57
Total Common Equity
4,3354,3614,3602,1141,6781,184
Minority Interest
0.450.47----
Shareholders' Equity
4,3364,3614,3602,1141,6781,184
Total Liabilities & Equity
5,9025,8255,6513,8752,4321,761
Total Debt
650.23374.59349.51434.1478.92158.12
Net Cash (Debt)
717.811,6511,83151.0541.51109.64
Net Cash Growth
-45.50%-9.83%3485.91%22.99%-62.14%-
Net Cash Per Share
1.824.144.720.140.120.31
Filing Date Shares Outstanding
396.81396.81399.9400.01352.75346.7
Total Common Shares Outstanding
396.81397.89400.01352.75352.75346.7
Working Capital
2,0611,9102,287345.02411.91438.26
Book Value Per Share
10.9310.9610.905.994.763.42
Tangible Book Value
4,1544,1794,1771,9401,4841,094
Tangible Book Value Per Share
10.4710.5010.445.504.213.15
Buildings
-833.02719.62395.96329.31316.78
Machinery
-1,6491,470782.58657567.68
Construction In Progress
-630.57375.86946.39334.1167.57
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.